Latest Share Repurchase News

Page 5 of 19
Embelton is seeking shareholder approval to leave the ASX, arguing that thin trading and annual listing costs of about $160,000 no longer justify the quotation. The company also proposes an $11 per share buy-back for other shareholders, subject to approval.
Victor Sage
Victor Sage
4 Nov 2026
Prudential Financial delivered lower third-quarter adjusted earnings as a sales suspension in Japan cut into an otherwise mixed performance. PGIM attracted strong third-party inflows and US annuity sales reached a record, but the company’s central earnings engine weakened year on year.
Victor Sage
Victor Sage
4 Nov 2026
Assurant lifted its 2026 earnings outlook after reporting strong third-quarter growth across its Lifestyle and Housing businesses. The insurer also plans to increase share repurchases to US$350 million, although catastrophe losses and reserve development remain important variables.
Victor Sage
Victor Sage
4 Nov 2026
International Flavors & Fragrances raised the lower end of its 2026 sales and adjusted EBITDA guidance after broad-based third-quarter growth. The stronger operating result sits alongside a US$134 million pre-tax continuing-operations loss and a costly Food Ingredients separation still awaiting completion.
Victor Sage
Victor Sage
4 Nov 2026
Arista Networks delivered third-quarter revenue well above its own guidance, with sales reaching US$3.66 billion and GAAP net income hitting US$1.56 billion. The networking specialist is now guiding to as much as US$4.0 billion in fourth-quarter revenue as it expands its AI infrastructure portfolio.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Amgen delivered 8% third-quarter revenue growth and a 19% increase in GAAP diluted EPS, while newer medicines continued to expand. The result came alongside sharp declines in Prolia and XGEVA sales from biosimilar competition and a busy pipeline of late-stage programmes.
Victor Sage
Victor Sage
4 Nov 2026
Booking Holdings delivered strong third-quarter booking and adjusted earnings growth, but a US$900 million revenue reduction linked to an FTC matter pushed reported revenue and net income lower. Its fourth-quarter guidance also points to softer travel demand and continuing disruption from the Middle East conflict.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Expeditors delivered a sharp third-quarter acceleration, with revenue up 42% and diluted EPS up 62% as air and ocean volumes strengthened. Demand from AI infrastructure customers helped drive growth, but constrained capacity and Asian port disruption remain material risks.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Zebra Technologies delivered a sharp third-quarter acceleration, lifted its full-year outlook and generated US$661 million of free cash flow in the first nine months. The gains came with pressure from memory costs, a lower gross margin and a sizeable current debt balance.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Aptiv delivered 2% third-quarter revenue growth and returned to statutory profit, while maintaining its full-year 2026 outlook after the spin-off of its Electrical Distribution Systems business. The result was supported by North American growth and share buybacks, but adjusted EBITDA and margins declined.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Yum! Brands has completed its Pizza Hut exit, lifting third-quarter GAAP earnings with a US$1.7 billion pretax gain. Beneath that windfall, KFC delivered strong expansion while Taco Bell's US sales weakened sharply.
Victor Sage
Victor Sage
4 Nov 2026
Pfizer has lifted its 2026 revenue and adjusted earnings guidance after a quarter in which newer and acquired medicines grew strongly enough to offset steep declines in COVID-19 products. Overall revenue was flat, while reported net income fell 8%.
Victor Sage
Victor Sage
4 Nov 2026

Browse the archive

Full archive